XML 86 R70.htm IDEA: XBRL DOCUMENT v3.25.3
Note 8 - Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Balance $ 691,409 $ 675,361
Currency translation adjustments 10,986 16,048
Balance 702,395 691,409
Accumulated goodwill impairments 0  
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]    
Balance [1]   0
Life Science Products [Member]    
Balance 0 316,326
Currency translation adjustments 0 0
Balance 0 0
Accumulated goodwill impairments 0  
Life Science Products [Member] | Cumulative Effect, Period of Adoption, Adjusted Balance [Member]    
Balance [1]   (316,326)
Life Science Services [Member]    
Balance 0 359,035
Currency translation adjustments 0 0
Balance 0 0
Accumulated goodwill impairments 0  
Life Science Services [Member] | Cumulative Effect, Period of Adoption, Adjusted Balance [Member]    
Balance [1]   (359,035)
Sample Management Solutions [Member]    
Balance 494,649 0
Currency translation adjustments 10,986 16,048
Balance 505,635 494,649
Accumulated goodwill impairments 0  
Sample Management Solutions [Member] | Cumulative Effect, Period of Adoption, Adjusted Balance [Member]    
Balance [1]   478,601
Multiomics [Member]    
Balance 196,760 0
Currency translation adjustments 0 0
Balance 196,760 196,760
Accumulated goodwill impairments $ 0  
Multiomics [Member] | Cumulative Effect, Period of Adoption, Adjusted Balance [Member]    
Balance [1]   $ 196,760
[1] Changes to the Company’s operating segments effective October 1, 2023 resulted in a change to the Company’s reporting units. As a result of this segment realignment, the Company allocated goodwill to the reporting units existing under the new organizational structure on a relative fair value basis as of October 1, 2023.